Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American Journal of Physiology

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPCELL.1993.265.2.C477PMID 8396328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways.

  1992cited by this paper
• Lack of correlation between the activation of the Ca(2+)-phosphatidylinositol cascade and the regulation of DNA synthesis in the dog thymocyte.

  1992cited by this paper
• Lack of correlation between the activation of the Ca2+-phosphatidylinositol cascade and the regulation of DNA synthesis in the dog thyrocyte

  1992cited by this paper
• Insulin and platelet-derived growth factor stimulate phosphorylation of the c-raf product at serine and threonine residues in intact cells.

  1991cited by this paper
• Linkage between blood coagulation and inflammation: stimulation of neutrophil tissue kallikrein by thrombin.

  1991cited by this paper
• Protein kinase C-induced stimulation or inhibition of cellular proliferation in a murine macrophage tumor cell line.

  1990cited by this paper
• The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation.

  1990cited by this paper
• Bradykinin blocks the action of EGF, but not PDGF, on fibroblast division

  1989cited by this paper
• Study of the growth factor requirements of human bone-derived cells: a comparison with human fibroblasts.

  1989cited by this paper
• Reinforcement of signal generation at B2 bradykinin receptors by insulin, epidermal growth factors, and other growth factors.

  1989cited by this paper
• The epidermal growth factor receptor tyrosine kinase in liver epithelial cells. The effect of ligand-dependent changes in cellular location.

  1989cited by this paper
• Signal transduction pathways in mitogenesis.

  1989cited by this paper
• Epidermal growth factor stimulates phospholipase A2 in vasopressin-treated rat glomerular mesangial cells.

  1988cited by this paper
• An increase in intracellular free Ca2+ associated with serum-free growth stimulation of Swiss 3T3 fibroblasts by epidermal growth factor in the presence of bradykinin.

  1988cited by this paper
• Inhibition of DNA synthesis by protein kinase C-activating phorbol esters in NIH/3T3 cells.

  1988cited by this paper
• Immunohistochemical assessment of the effect of chemical and mechanical stimuli on cAMP and prostaglandin E levels in human gingival fibroblasts in vitro.

  1988cited by this paper
• A rapid separation method for inositol phosphates and their isomers.

  1987cited by this paper
• Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity.

  1987cited by this paper
• Growth inhibition by protein kinase C late in mitogenesis

  1987cited by this paper
• On the regulation of deoxyribonucleotide synthesis.

  1985cited by this paper
• Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1.

  1985cited by this paper
• Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths.

  1985cited by this paper
• Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor.

  1984cited by this paper
• Lys-bradykinin stimulates Na+ influx and DNA synthesis in cultured human fibroblasts.

  1983cited by this paper
• beta-Adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes.

  1983cited by this paper
• Dynamics of pyrimidine deoxynucleoside triphosphate pools in relationship to DNA synthesis in 3T6 mouse fibroblasts.

  1983cited by this paper
• Role of stimulation of arachidonic acid release in the proliferative response of 3T3 mouse fibroblasts to platelet‐derived growth factor

  1982cited by this paper
• Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors

  1979cited by this paper
• Fibroblast heterogeneity and prostaglandin regulation of subpopulations.

  1977cited by this paper
• Biochemical characterization of collagens synthesized by fibroblasts derived from normal and diseased human gingiva.

  1976cited by this paper

• The Mitigating Effect and Mechanism of Polydeoxyribonucleotide Against Zoledronic Acid-Induced Growth Suppression of Human Gingival Fibroblasts

  2025cites this paper
• Differential Expression of Kinin Receptors in Human Wet and Dry Age-Related Macular Degeneration Retinae

  2020cites this paper
• Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway

  2019cites this paper
• Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models

  2019cites this paper
• Bradikininski receptori u ishemijskom moždanom udaru

  2019cites this paper
• Targeting vasoactive peptides for managing calcific aortic valve disease

  2017cites this paper
• In vitro effects of dental cements on hard and soft tissues associated with dental implants

  2017cites this paper
• Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice

  2016cites this paper
• Kinin‐B1 and B2 receptor activity in proliferation and neural phenotype determination of mouse embryonic stem cells

  2015cites this paper
• Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy

  2015cites this paper
• Cytotoxicity comparison of the nanoparticles deposited on latex rubber bands between the original and stretched state

  2014influential citation
• Involvement of heparan sulfate in the renoprotective effects of imidapril, an angiotensin-converting enzyme inhibitor, in diabetic db/db mice

  2014cites this paper
• Establishing a gingival fibroblast phenotype in a perfused degradable polyurethane scaffold: mediation by TGF-β1, FGF-2, β1-integrin, and focal adhesion kinase.

  2014cites this paper
• Perfused culture of gingival fibroblasts in a degradable/polar/hydrophobic/ionic polyurethane (D-PHI) scaffold leads to enhanced proliferation and metabolic activity.

  2013cites this paper
• Adenosine A2B receptor-mediated VEGF induction promotes diabetic glomerulopathy

  2013cites this paper
• Cardinal Role of the Intrarenal Renin-Angiotensin System in the Pathogenesis of Diabetic Nephropathy

  2013cites this paper
• Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice

  2013cites this paper
• Regulation and Maintenance of Vascular Tone and Patency in Cardiovascular Health and Disease

  2012cites this paper
• Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease

  2012cites this paper
• The platelet-derived growth factor system in renal disease: an emerging role of endogenous inhibitors.

  2012cites this paper
• Increased susceptibility to hypertensive renal disease in streptozotocin-treated diabetic rats is not modulated by salt intake

  2012cites this paper
• Reactive Oxygen Species in the Pathogenesis of Chronic Kidney Disease: Lessons Derived from Diabetic Nephropathy 118

  2012cites this paper
• Bradykinin Type-2 Receptor Expression Correlates with Age and Is Subjected to Transcriptional Regulation

  2011cites this paper
• Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition

  2011cites this paper
• Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.

  2011cites this paper
• New pharmacological treatments for improving renal outcomes in diabetes

  2010cites this paper
• New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease

  2010cites this paper
• Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats.

  2009cites this paper
• Enalapril Alters Expression of Key Growth Factors in Experimental Diabetic Retinopathy

  2009cites this paper
• Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney

  2009cites this paper
• Chronic angiotensin (1–7) injection accelerates STZ-induced diabetic renal injury

  2008cites this paper
• Vitamin D and diabetic nephropathy

  2008cites this paper
• Olmesartan Ameliorates Progressive Glomerular Injury in Subtotal Nephrectomized Rats through Suppression of Superoxide Production

  2008cites this paper
• ANGIOTENSIN CONVERTING ENZYME 2 IN THE KIDNEY

  2008cites this paper
• Overexpression of angiotensinogen increases tubular apoptosis in diabetes.

  2008cites this paper
• Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase

  2008cites this paper
• Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

  2008cites this paper
• The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease

  2007cites this paper
• Pourquoi ? Comment ? Perspectives

  2007cites this paper
• Bradykinine et néphroprotection - Pourquoi ? Comment ? Perspectives

  2007cites this paper
• Lovastatin induces the expression of bradykinin type 2 receptors in cultured human coronary artery endothelial cells.

  2007cites this paper
• Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.

  2007cites this paper
• Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus

  2007cites this paper
• ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.

  2007cites this paper
• PATHOBIOLOGICAL ASPECTS OF NONRHEUMATIC AORTIC VALVE STENOSIS

  2007cites this paper
• [New perspectives for bradykinin in nephroprotection].

  2007cites this paper
• The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin–angiotensin system

  2006cites this paper
• Effects of Blocking the Renin-Angiotensin System on Expression and Translocation of Protein Kinase C Isoforms in the Kidney of Diabetic Rats

  2006cites this paper
• Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy

  2006cites this paper
• Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.

  2006cites this paper
• Angiotensin II and Its Receptors in the Pathogenesis of Diabetic Nephropathy

  2006cites this paper
• Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

  2006cites this paper
• Effect of rhPDGF-BB on bone turnover during periodontal repair.

  2006cites this paper
• Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts.

  2005cites this paper
• Angiotensin II Mediates High Glucose-Induced TGF-β1 and Fibronectin Upregulation in HPMC through Reactive Oxygen Species

  2005cites this paper
• Blockade of the Renin-Angiotensin System Increases Plasma Adiponectin Levels in Type-2 Diabetic Patients with Proteinuria

  2005cites this paper
• Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin–angiotensin system

  2005cites this paper
• Heterogenous nuclear ribonucleoprotein F modulates angiotensinogen gene expression in rat kidney proximal tubular cells.

  2005cites this paper
• Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy.

  2005cites this paper
• Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

  2004cites this paper
• Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

  2004cites this paper
• Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor β1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat

  2004cites this paper
• Angiotensin Converting Enzyme-2 (ACE2) and its Possible Roles in Hypertension, Diabetes and Cardiac Function

  2004cites this paper
• Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination?

  2004cites this paper
• AT2 renal aspects

  2004cites this paper
• Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin

  2003cites this paper
• Pathogenesis of diabetic retinopathy and the renin‐angiotensin system

  2003cites this paper
• Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2

  2003cites this paper
• Role of bradykinin in renoprotective effects by angiotensin II type 1 receptor antagonist in salt-sensitive hypertension.

  2003cites this paper
• The renin-angiotensin system in blacks: Active, passive, or what?

  2003cites this paper
• Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure

  2003cites this paper
• New Aspects of Ace Inhibition: Importance of ACE co-localization with angiotensin and bradykinin receptors

  2003cites this paper
• Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

  2003cites this paper
• Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension

  2003cites this paper
• Additive effects of hypertension and diabetes on renal cortical expression of PKC-alpha and -epsilon and alpha-tubulin but not PKC-beta 1 and -beta 2.

  2003cites this paper
• Angiotensin II and the glomerulus: Focus on diabetic kidney disease

  2003cites this paper
• Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

  2003cites this paper
• Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.

  2003cites this paper
• Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.

  2002cites this paper
• Haemodynamics in microvascular complications in type 1 diabetes

  2002cites this paper
• Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure.

  2002cites this paper
• Blood Pressure Control Early In Diabetes: A Balance Between Angiotensin Ii And Nitric Oxide

  2002cites this paper
• Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin.

  2002cites this paper
• Hypertension and diabetes

  2002cites this paper
• Kinins and kinin receptors in the pathogenesis of heart failure

  2002cites this paper
• Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy

  2001cites this paper
• A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors.

  2001cites this paper
• ACE and diabetes

  2001cites this paper
• Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat

  2001cites this paper
• Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression

  2001cites this paper
• Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

  2001cites this paper
• Blood pressure in diabetic nephropathy – current controversies

  2001cites this paper
• Blood pressure in diabetic nephropathy--current controversies.

  2001cites this paper
• Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

  2001cites this paper
• Renin-angiotensin system gene expression in post-transplant hypertension predicts allograft function.

  2000cites this paper
• Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.

  2000cites this paper
• Bradykinin-induced inhibition of cell proliferation and tyrosine kinase activity in rat mesangial cells.

  2000cites this paper
• Protein kinase C activation and its pharmacological inhibition in vascular disease

  2000cites this paper
• Kinin-degrading pathways in the human heart.

  2000cites this paper
• T cell design for therapy in autoimmune demyelinating disease.

  2000cites this paper